Cargando…
Ribavirin for Lassa Fever Postexposure Prophylaxis
Autores principales: | Hadi, Christiane M., Goba, Augustine, Khan, Sheik Humarr, Bangura, James, Sankoh, Mbalu, Koroma, Saffa, Juana, Baindu, Bah, Alpha, Coulibaly, Mamadou, Bausch, Daniel G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3294560/ https://www.ncbi.nlm.nih.gov/pubmed/21122249 http://dx.doi.org/10.3201/eid1612.100994 |
Ejemplares similares
-
Postexposure prophylaxis for Lassa fever: Experience from a recent outbreak in Nigeria
por: Isa, Samson E., et al.
Publicado: (2016) -
Lassa fever-induced hearing loss: The neglected disability of hemorrhagic fever
por: Ficenec, Samuel C., et al.
Publicado: (2020) -
Time to reconsider the role of ribavirin in Lassa fever
por: Salam, Alex Paddy, et al.
Publicado: (2021) -
Rabies postexposure prophylaxis survey--Kentucky, 1994.
por: Auslander, M, et al.
Publicado: (1997) -
HIV postexposure prophylaxis in the 21st century.
por: Henderson, D K
Publicado: (2001)